Search results
Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric...
WTNH-TV New Haven· 6 days agoNovartis today announced that the U.S. Food and Drug Administration (FDA) approved Lutathera®...
Novartis Gets FDA Approval for Lutathera in Pediatric Treatment
Market Watch· 6 days agoNovartis said federal regulators have approved its Lutathera therapy as a treatment for pediatric patients with certain gastroenteropancreatic neuroendocrine</ ...
Edison Oncology's Orotecan®: A Brighter Future For The Treatment of Recurrent Pediatric Cancers
International Business Times· 10 hours agoEdison Oncology, a Biopharmaceutical company that develops and commercializes new therapies targeting the fight against cancer, is developing a medication that makes the treatment< ...
Novartis bags paediatric FDA label expansion for Lutathera
Pharmaceutical Technology via Yahoo Finance· 5 days agoNovartis did not disclose the detailed results of the trial but noted that...candidate, FPI-2265 is...
Cancer and emergency surgery have only motivated Phyllis Viagran
San Antonio Express-News· 3 days agoBy the end of January, the pain was so “unbearable” her primary physician ordered a scan that would...
Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
Zacks via Yahoo Finance· 3 days agoThe drug is already approved for treating SSTR+ GEP-NETs in adults. The approval for use in children...
Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market
Investor's Business Daily· 4 days agoAnalysts polled by FactSet expect $3.66 billion in 2029. Novartis also makes a...
Bristol Myers to cut 6% of workforce, trim drug pipeline
BioPharma Dive via Yahoo Finance· 5 days agoThose deals have brought in prospective treatments for schizophrenia, a type of neuroendocrine tumor...
MD Anderson Research Highlights for April 24, 2024
Newswise· 6 days agoThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These adva
Novartis raises forecasts as top drug sales beat Wall Street estimates
BioPharma Dive via Yahoo Finance· 6 days agoDemand for the former has grown following new treatment guidelines for heart failure, while...